StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Analyst target changes matter most when the new target creates a material gap versus current price or confirms a recent catalyst.
What happened, with direct paths to the underlying reporting
Goldman Sachs raises Ionis Pharmaceuticals price target to $69 from $66.
Target: $69
Posted price: $54.04
Analyst firm: Goldman Sachs
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.